Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

4.17
Delayed Data
As of Oct 18
 -0.08 / -1.88%
Today’s Change
3.18
Today|||52-Week Range
7.98
-3.25%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close4.25
Today’s open4.26
Day’s range4.08 - 4.26
Volume164,079
Average volume (3 months)377,601
Market cap$214.9M
Dividend yield--
Data as of 3:59pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)-820.59%
Earnings growth (this year)+59.11%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.29

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...+0.17+4.00%
ARWRArrowhead Pharmaceut...-0.02-0.51%
CDXSCodexis Inc-0.05-0.68%
BCLIBrainstorm Cell Ther...+0.20+4.98%
Data as of 3:59pm ET, 10/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$57.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts